Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...
JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, presented results from an expanded cohort of 500 patients in the ALIGN-AR Pivotal Trial ...
JAKKS Pacific Unveils Exciting New SIMPSONS Collectibles at WonderCon 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback